Search company, investor...

Predict your next investment

Hedge Fund

Investments

1

Portfolio Exits

1

About Hound Partners

Hound Partners is a New York-based hedge fund manager.

Headquarters Location

101 Park Avenue 48th Floor

New York, New York, 10178,

United States

212-984-2326

Want to inform investors similar to Hound Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Hound Partners News

Citi names former Goldman Sachs managing director as global head of prime sales

Oct 24, 2022

The Trade Citi names former Goldman Sachs managing director as global head of prime sales New head joins from Hound Partners where he served as COO and before that, spent 25 years at Goldman Sachs. Citi has appointed Tom Lynch, formerly of Goldman Sachs, as its new global head of prime sales. Lynch joins Citi from Hound Partners, where he has spent the past two years serving as chief operating officer. Prior to that, he spent 25 years at Goldman Sachs, leading various teams across prime services sales, capital introduction and capital raising. Based in New York, Lynch will report directly to Fater Belbachir, global head of equities at Citi. Lynch’s appointment follows that of Sebastien Mailleux and Tim Tomalin-Reeves, who were appointed as global co-heads of prime services in June this year. The pair will work alongside Lynch to further grow Citi’s prime services offering. “Tom spent 25 years at Goldman Sachs where he held a number of senior positions within the prime brokerage and capital introductions organisations,” said Belbachir in an internal memo seen by The TRADE. “This experience, combined with his tenure as a COO at Hound Partners, will bring a wealth of client connectivity and leadership to our equities organisation.”

Hound Partners Investments

1 Investments

Hound Partners has made 1 investments. Their latest investment was in Lev Pharmaceuticals as part of their Unattributed VC on October 10, 2006.

CBI Logo

Hound Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/11/2006

Unattributed VC

Lev Pharmaceuticals

$21M

Yes

Date

10/11/2006

Round

Unattributed VC

Company

Lev Pharmaceuticals

Amount

$21M

New?

Yes

Co-Investors

Sources

Hound Partners Portfolio Exits

1 Portfolio Exit

Hound Partners has 1 portfolio exit. Their latest portfolio exit was Lev Pharmaceuticals on October 07, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/7/2008

Acquired

$99M

Date

10/7/2008

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

Hound Partners Team

1 Team Member

Hound Partners has 1 team member, including current Founder, Jonathan Auerbach.

Name

Work History

Title

Status

Jonathan Auerbach

Stark Investments, and W.R. Huff Investment Arm

Founder

Current

Name

Jonathan Auerbach

Work History

Stark Investments, and W.R. Huff Investment Arm

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.